Reaction Details |
| Report a problem with these data |
Target | Vasopressin V1a receptor |
---|
Ligand | BDBM521174 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | Cellular In Vitro Assay for Determining Vasopressin Receptor Activity |
---|
IC50 | 1.95±n/a nM |
---|
Citation | Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H Substituted triazole derivatives and uses thereof US Patent US11149023 Publication Date 10/19/2021 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Vasopressin V1a receptor |
---|
Name: | Vasopressin V1a receptor |
Synonyms: | AVPR V1a | AVPR1 | AVPR1A | Antidiuretic hormone receptor 1a | V1AR_HUMAN | V1aR | VASOPRESSIN V1A | Vascular/hepatic-type arginine vasopressin receptor | Vasopressin V1 receptor | Vasopressin V1a receptor | Vasopressin receptor |
Type: | Receptor |
Mol. Mass.: | 46820.18 |
Organism: | Homo sapiens (Human) |
Description: | P37288 |
Residue: | 418 |
Sequence: | MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAV
TFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGP
DWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFV
LSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFIC
YNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAY
IVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCV
QSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST
|
|
|
BDBM521174 |
---|
n/a |
---|
Name | BDBM521174 |
Synonyms: | N-{3-[3-(4-Chlorophenyl)-5-oxo-1-({1-[3-(trifluoromethyl)pyridin-2-yl]-1H-1,2,4-triazol-3-yl}methyl)-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-3,3-difluoroazetidine-2-carboxamide Hydrochloride (Diastereomeric Mixture) | US11149023, Example 69 |
Type | Small organic molecule |
Emp. Form. | C24H18ClF8N9O2 |
Mol. Mass. | 651.899 |
SMILES | FC(F)(F)C(Cn1c(nn(Cc2ncn(n2)-c2ncccc2C(F)(F)F)c1=O)-c1ccc(Cl)cc1)NC(=O)C1NCC1(F)F |
Structure |
|